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Abstract
Background: The National Institutes of Health (NIH) Roadmap places special emphasis on “bench-to-bedside”
research, or the “translation” of basic science research into practical clinical applications. The Clinical and
Translational Science Awards (CTSA) Consortium is one example of the large investments being made to develop a
national infrastructure to support translational science, which involves reducing regulatory burdens, launching new
educational initiatives, and forming partnerships between academia and industry. However, while numerous
definitions have been suggested for translational science, including the qualitative T1-T4 classification, a consensus
has not yet been reached. This makes it challenging to tract the impact of these major policy changes.
Methods: In this study, we use a bibliometric approach to map PubMed articles onto a graph, called the Triangle
of Biomedicine. The corners of the triangle represent research related to animals, cells and molecules, and humans;
and, the position of a publication on the graph is based on its topics, as determined by its Medical Subject
Headings (MeSH). We define translation as movement of a collection of articles, or the articles that cite those
articles, towards the human corner.
Results: The Triangle of Biomedicine provides a quantitative way of determining if an individual scientist, research
organization, funding agency, or scientific field is producing results that are relevant to clinical medicine. We
validate our technique using examples that have been previously described in the literature and by comparing it to
prior methods of measuring translational science.
Conclusions: The Triangle of Biomedicine is a novel way to identify translational science and track changes over
time. This is important to policy makers in evaluating the impact of the large investments being made to accelerate
translation. The Triangle of Biomedicine also provides a simple visual way of depicting this impact, which can be far
more powerful than numbers alone.
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Background
In biomedicine, translational science is research that has
gone from “bench” to “bedside”, resulting in applications
such as drug discovery that can benefit human health
[1-6]. However, this is an imprecise description; and,
while numerous definitions have been suggested, includ-
ing the qualitative T1-T4 classification [7], a consensus
has not yet been reached. Several bibliometric tech-
niques have been developed to quantitatively place pub-
lications along the translational spectrum. Narin
assigned journals to fields, and then grouped these fields
into either “Basic Research” or “Clinical Medicine”
[8-10]. Narin also developed another classification called
research levels, in which journals are assigned to “Cli-
nical Observation” (Level 1), “Clinical Mix” (Level 2),
“Clinical Investigation” (Level 3), or “Basic Research”
(Level 4) [8]. He combines Levels 1 and 2 into “Clinical
Medicine” and Levels 3 and 4 to “Biomedical Research”.
Lewison showed that the research level of individual ar-
ticles can be determined from keywords within the arti-
cles’ titles and addresses, and he defines the average
research level of a collection of articles as the mean of
the research levels of those articles [11-13].
In this study, we analyze the 20 million publications in
the National Library of Medicine’s PubMed database by
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We divide basic science into two subcategories, research
done on animals or other complex organisms and research
done on the cellular or molecular level. We believe it is
important to make this distinction due to the rapid in-
crease in “-omics” research and related fields in recent
years. (2) We classify articles using their Medical Subject
Headings (MeSH), which are assigned based on the con-
tent of the articles. Journal fields, title keywords, and ad-
dresses only approximate an article’s content. (3) We map
the classification scheme onto a graphical diagram, which
we call the Triangle of Biomedicine, which makes it pos-
sible to visualize patterns and identify trends over time.
Methods
Article classification technique
Using a simple algorithm based on an article’s MeSH de-
scriptors, we determined whether each article in
PubMed contained research related to three broad topic
areas—animals and other complex organisms (A), cells
and molecules (C), or humans (H). An article can have
more than one topic area. Articles about both animals
and cells are classified as AC, articles about both animals
and humans are AH, articles about cells and humans are
CH, and articles about all three are ACH. Articles that
have none of these topic areas are unclassified by this
method.
To determine an article’s topics, we took advantage of
the fact that MeSH is organized as a hierarchical tree, and
the three topic areas correspond to particular MeSH nodes
and their subtrees. H is mapped to all MeSH codes under
the subtrees B01.050.150.900.649.801.400.112.400.400
(Human) and M01 (Person); A is mapped to all codes
under the subtree B01 (Eukaryota) except the code for
Humans; and C is mapped to the subtrees A11 (Cells),
B02 (Archaea), B03 (Bacteria), B04 (Viruses), G02.111.570
(Molecular Structures), and G02.149 (Chemical Pro-
cesses). These mappings are not perfect. A much more
complicated MeSH-based classification technique could
have been developed; however, keeping the definition of
the three areas simple did not seem to limit our analysis,
and it made the results easier to interpret.
The triangle of biomedicine
Several groups have created “maps of science” to visually
depict the structure of literature by showing the relation-
ships among different fields of science [14-20]. In these
maps, a reference system is defined, over which data
about publications and citations are placed. A reference
system can be chosen specifically to highlight certain attri-
butes of the data, such as emerging areas of innovation or
interdisciplinary research.
In order to identify translational research, we
constructed a trilinear graph [21], where the three topic
areas are placed at the corners of an equilateral triangle,
with A on the lower-left, C on the top, and H on the
lower-right. The midpoints of the edges correspond to
AC, AH, and CH articles, and the center of the triangle
corresponds to ACH articles.
An article can be plotted on the Triangle of Biomedi-
cine according to the MeSH descriptors that have been
assigned to it. For example, if only human descriptors,
and no animal or cell descriptors have been assigned to
an article, then it is classified as an H article and placed
at the H corner. An article with both animal and cell de-
scriptors, and no human descriptors, is classified as an
AC article and placed at the AC point. A collection of
articles is represented by the average position of its arti-
cles. Although an individual article can only be mapped
to one of seven points, a collection of articles can be
plotted anywhere in the triangle.
An imaginary line, the Translational Axis, can be
drawn from the AC point to the H corner. The position
of one or more articles when projected onto this axis is
the Translational Index (TI). By distorting the Triangle
of Biomedicine by bringing the A and C corners together
at the AC point, the entire triangle can be collapsed
down along the Translational Axis to the more trad-
itional depiction of translational science being a linear
path from basic to clinical research. In other words, the
Triangle of Biomedicine does not replace the traditional
linear view, but rather provides additional clarity into
the path research takes towards translation.
Mathematical description of the triangle of biomedicine
The Triangle of Biomedicine is drawn as an equilateral tri-
angle, whose corners correspond to A, C, and H topic
areas. On a Cartesian system, each corner is a distance of
1 from the origin, with the A corner at (x,y)=(−sqrt(3)/2,-
0.5), the C corner at (0,1), and the H corner at (sqrt(3)/2,-
0.5). The AC, AH, and CH points are midway along the
edges of the triangle, and the ACH point is located at the
origin at (0,0). The Translational Axis is a line from the
AC point, through the origin, to the H corner. The pos-
ition of a point projected onto the Translational Axis is its
Translational Index (TI). For example, the A, AC, or C
points have TI=−0.5; the AHC point has TI=0; the AH
and CH points have TI=0.25; and the H point has TI=1.
A collection of articles with mostly human studies that in-
cludes a small amount of basic science research will be
close to the H corner, but not directly on it, and it will
have a TI slightly less than 1.
Datasets used to validate the triangle of biomedicine
Our datasets are 1) a snapshot of 20,032,189 PubMed ar-
ticles and their associated MeSH descriptors and cita-
tions from December 24, 2010 (http://pubmed.org); 2)
broad journal headings from the NLM Catalog database
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grees and publications of 12,729 Harvard Medical
School faculty taken from the Harvard Catalyst Profiles
website (http://connects.catalyst.harvard.edu/profiles) in
December, 2010. Each of these sources is publicly
available.
Corrected citation counts
Although we are using all PubMed articles for this study,
PubMed derives its citation data (one article citing an-
other) from PubMed Central (PMC), which represents
only a subset of PubMed articles. As a result, the cit-
ation counts in PubMed are underestimates of the total
number of times that articles have actually been cited.
We therefore define a “corrected citation count” for an
article by dividing each citation by the percentage of
publications of the citing article’s type that are in PMC.
For example, since 4.9% of H articles and 17.1% of C ar-
ticles are in PMC, if an article has been cited in PMC by
one H article and two C articles, its corrected citation
count is 1/0.049 +2/0.171= 32.1. The assumption is that
for articles of a given type, the ones in PMC cite articles
the same way as the ones that are not in PMC.
Other citation databases exist, such as Thomson Reu-
ters’ Web of Science (WoS), Elsevier’s Scopus, and Goo-
gle Scholar. While there are large overlaps among these
databases, there are also significant differences, which
means that none of them are complete, and there will be
biases regardless of which database is used [22]. We
chose PMC because it is the only one that is freely avail-
able to download in its entirety, and it is linked to
PubMed and MeSH.
To gain a general sense of the differences between cit-
ation databases, we compared PMC and WoS for
174,395 articles written by Harvard faculty that we iden-
tified in both databases. Table 1b compares the PMC
corrected citation counts to the WoS citation counts,
broken into A-C-H categories. Although the PMC
corrected citation counts were higher on average than
WoS (possibly due to the different distributions of arti-
cles by year in PMC and WoS), the ratios between cat-
egories were similar. For example, in both databases,
ACH had the highest citation count and H had the low-
est (with the exception of unclassified articles), with a ra-
tio between ACH and H of 2.53 in PMC and 2.43 in
WoS. Since the ratio determines the position on the Tri-
angle of Biomedicine, this suggests that we would have
had similar results using WoS instead of PMC.
Mapping A-C-H categories to Narin’s basic-clinical
classification scheme
The National Library of Medicine (NLM) classifies
journals into different disciplines, such as microbiology,
pharmacology, or neurology, with the use of Broad
Journal Headings. We used Narin’s mappings to group
these disciplines into basic research or clinical medicine.
Individual articles were given a “basic research” score of
1 if they were in a basic research journal and 0 if they
were in a “clinical medicine” journal. For each A-C-H
category, a weighted average of its articles’ scores was
calculated, with the weights being the inverse of the total
number of basic research (4,316,495) and clinical medi-
cine (11,689,341) articles in PubMed. That gives a nu-
meric value for the fraction of articles within a category
that are basic research, which is corrected for the fact
that PubMed as a whole has a greater number of clinical
medicine articles.
Mapping A-C-H categories to Narin’s four-level
classification scheme
For each of his four research levels, Narin selected a proto-
type journal to conduct his analyses: The Journal of the
American Medical Association (JAMA, Level 1), The New
England Journal of Medicine (NEJM, Level 2), The Journal
of Clinical Investigation (JCI, Level 3), and The Journal of
Biological Chemistry (JBC, Level 4). Each is widely con-
sidered a leading journal and has over 25,000 articles
spanning more than 50 years. For each A-C-H cate-
gory, we determined the number of articles from each
of these four journals and calculated a weighted ave-
rage of their research levels, with the weights being the
inverse of the total number of articles each journal has
in PubMed.
Results
Article classification
Table 1a lists the number of articles that map to each
A-C-H category. The largest category is H, representing
43.3% of the articles in PubMed. About 19% of articles
do not fit into any category, and therefore cannot be
classified by this method. Many of these articles are in
areas such as history of medicine and social science, and
a third of them simply have no MeSH descriptors
assigned to them yet.
Comparing A-C-H categories to Narin’s classification
schemes
To validate our MeSH-based classification algorithm, we
used an approach similar to Lewison and compared our
A-C-H categories to Narin’s two classification schemes.
In both cases, our method was consistent with Narin’s:
1) If we give articles that Narin would classify as “basic
research” as c o r eo f1a n d“clinical medicine” as c o r eo f
0, then H articles have a basic research score of 0.125,
meaning they are mostly in clinical journals, while A
and C articles have scores of 0.634 and 0.911,
respectively, meaning they are mostly in basic research
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contain progressively more basic research, in that order.
2) Using Narin’s research levels, H articles have a score
of 1.59, which is between his two Clinical Medicine
levels, Clinical Observation (Level 1) and Clinical
Mix (Level 2). A and C articles have research levels
of 3.15 and 3.78, respectively, which are between the
two Biomedical Research levels, Clinical
Investigation (Level 3) and Basic Research (Level 4).
AH and CH articles fall in the middle, between
Levels 2 and 3; and, ACH and AC are both
Biomedical Research.
Mapping disciplines to the triangle of biomedicine
In Figure 1, disciplines, as defined by NLM Broad Journal
Headings, are plotted onto the Triangle of Biomedicine by
averaging the position of all of the individual articles in
that discipline. The size of the circle is proportional to the
number of articles. As one would expect, the fields closest
to the A, C, and H corners are veterinary medicine, bac-
teriology, and nursing, respectively. Clinical specialties,
such as vascular diseases and general surgery contain arti-
cles that are primarily in the H corner. Disciplines typically
considered basic science, such as biochemistry and cell
biology, are near the AC point. Allergy and immunology is
the discipline closest to the ACH point.
The blue squares connected to each discipline indicate
the average position publications that cite articles in that
discipline. The angle and length of the connecting lines in-
dicate the average direction and speed of knowledge flow.
For example, articles that cite hematology studies include
more animal research than the field of hematology itself,
Table 1 Summary of categories
a Category Number of
articles
Percent of
PubMed
Number of
authors
MeSH
descriptors
Basic
research
Research
level
A 1,878,604 9.4% 3.42 10.42 0.634 3.15
C 826,426 4.1% 3.39 8.79 0.911 3.78
H 8,676,294 43.3% 3.24 10.02 0.125 1.59
AC 2,015,181 10.1% 3.96 13.25 0.795 3.68
AH 611,098 3.1% 3.02 10.88 0.463 2.10
CH 1,581,218 7.9% 4.68 12.60 0.562 2.85
ACH 714,372 3.6% 4.50 14.71 0.753 3.40
None 3,728,996 18.6% 2.28 2.27 0.494 2.28
b Category Percent
in PMC
Percent cited
in PMC
Mean PMC
citations
Corrected PMC
citations
Harvard corrected
citations
Harvard WoS
citations
A 5.5 31.6 1.23 16.2 56.7 40.4
C 17.1 50.8 4.85 36.0 97.1 60.1
H 4.9 22.5 0.71 13.7 51.8 32.4
AC 13.5 54.8 4.07 37.5 112.3 67.3
AH 6.3 34.8 1.65 23.8 83.9 55.1
CH 11.3 48.2 2.99 31.7 91.5 54.7
ACH 15.2 60.1 5.48 53.1 130.8 78.7
None 7.6 12.0 0.52 7.21 32.0 34.9
c Category Translational
fraction (TF)
Translational
distance (TD)
Translational
years (TY)
Translational
closeness (TC)
A 0.198 2.46 10.40 0.107
C 0.379 3.08 8.74 0.147
H 0.192 1.12 5.69 0.183
AC 0.392 2.76 8.26 0.175
AH 0.249 1.71 6.70 0.187
CH 0.364 1.90 6.03 0.246
ACH 0.430 2.22 5.81 0.246
None 0.089 2.10 13.39 0.059
Listed for each category are (a) the number of articles, the percent of all articles in PubMed, the average number of authors per article, the average number of
distinct MeSH descriptors that have been assigned to the articles, fraction of articles in basic research (vs basic research or clinical medicine) journals, the average
Research Level; (b) the percent of articles in the category that exist in PubMed Central (PMC), the percent of articles that have been cited by at least one article in
PMC, the mean number of times articles have been cited in PMC, the mean corrected number of PMC citations, the mean corrected number of PMC citations for
a sample of articles published by Harvard researchers, the mean number of Web of Science (WoS) citations for the same sample of Harvard publications; (c) the
Translational Fraction (TF), the Translational Distance (TD), the Translational Years (TY), and the Translational Closeness (TC).
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studies include more human research. Thus, the position
of a circle indicates the A-C-H composition of the re-
search in a discipline, while the square suggests the direc-
tion of that discipline’si m p a c t .
Identifying changes over time
As knowledge in a research area evolves, its position in
the Triangle of Biomedicine can move over time. Move-
ment towards the H corner can be considered a transition
in the focus of a research area from bench-to-bedside,
and movement in the opposite direction indicates a
return to basic science. Figure 2 shows some notable
examples:
1) Articles with a MeSH descriptor “Adipose Tissue,
Brown” (brown fat) were mostly focused on animal
research until the late 1990s, when a number of
related proteins were discovered and it was
subsequently found that brown fat also exists in
adult humans.
2) An almost immediate change in the focus of articles
with a MeSH descriptor “Influenza A Virus, H1N1
Subtype” (swine flu) occurred with the 2009
pandemic of the virus in humans.
3) Articles with MeSH descriptors “Cloning, Organism”
and “Genes, rRNA” have both moved in the
direction of animal research in recent years.
4) The position of articles with a MeSH descriptor
“Benzazepines” has swung in two directions with a
surge in clinical trials during the early 1980s and
again in the past five years, with a period of mostly
animal research in the middle.
5) Not surprisingly, articles flagged in PubMed as
Phase I clinical trials are near the H corner, and
Phase II, III, and IV trials are progressively closer.
6) The publications that cite NIH R01 grant numbers
cover a wide range of topics, and therefore are near
the ACH point, though there has been movement
towards the CH point over time.
7) PubMed as a whole has changed relatively little in
the past 30 years, with a large percentage of its
articles consistently in the H category.
Translation occurs through incremental steps rather than
giant leaps
Narin showed that articles in one research level primar-
ily cite other articles in the same research level. Less
common were citations in adjacent research levels, and
only rarely did an article cite another that is two or three
Figure 1 Disciplines mapped onto the Triangle of Biomedicine. The corners of the triangle correspond to animal (A), cellular or molecular
(C), and human (H) research. The dashed blue line indicates the Translational Axis from basic research to clinical medicine. The position of each
circle represents the average location of the articles in a discipline. The size of the circle is proportional to the number of articles in that
discipline. The color of the circle indicates the Translational Distance (TD)—the average number of citation generations needed to reach an H
article. The position of the light blue box connected to each discipline represents the average location of articles citing publications in that
discipline. To provide clarity, not all disciplines are shown.
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typically did not go from basic research directly to clin-
ical observation. Rather, it slowly passed through each of
the research levels along the path towards translation.
Figure 3 shows a similar pattern of information flow
within the Triangle of Biomedicine. In most cases, articles
in a particular A-C-H category cite other articles within
the same category. However, it is much more likely that an
article will cite articles in adjacent categories than in ones
on the opposite side of the triangle. Of all citations, 54%
are articles citing articles in the same category, 36% are ar-
ticles citing articles in adjacent categories (e.g., H citing
AH, AC citing ACH, or AH citing A), and only 10% are
articles citing articles in opposite categories (e.g., H citing
A, C citing AH, or AC citing H). In other words, basic sci-
ence research (A, AC, and C) rarely translates directly to
H articles. Instead, it first passes through an intermediate
stage (AH, ACH, and CH).
Translation takes many years
The amount of time from a basic science discovery to a
clinical intervention, the “translation lag”, can be many
years [23,24]. Contopoulos-Ioannidis found that only
25% of high impact basic science articles that had clear
therapeutic or preventative potential actually resulted in
a clinical trial after 20 years; and, when translation oc-
curs, it takes a median of 24 years from the initial basic
science discovery until the first highly cited human study
[25,26].
We use the concept of citation “generations” to measure
the translation lag of an article. If one article cites a second
article, which in turn cites a third article, then the second
article is one citation generation from the first, and the
third is two citation generations from the first. We assume
that in order for an article to have clinical impact, it must
reach an H article after some number of citation genera-
tions. While this does not guarantee that translation to
clinical practice will occur, it gives us a lower bound on
the amount of time it will take if it does. From this as-
sumption, we define the following metrics:
1) Translational Fraction (TF) is the fraction of articles
in a category that after some number of citation
generations eventually reaches an H article.
2) Translational Distance (TD) of an article is the
minimum number of citation generations needed to
reach an H article. The TD of a collection of articles
is the mean TD of the individual articles.
Figure 2 Translation over time. Each curve represents a different collection of articles: five based on MeSH descriptors, articles flagged in
PubMed as being associated with a clinical trial, articles that cite R01 grants, and all articles in PubMed. The markers indicate different time points,
with the largest marker indicating the position of the articles in 2010.
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of years it took to reach an H article. The TY of a
collection of articles is the mean TY of the
individual articles.
4) Translational Closeness (TC) is the average of the
inverse of the TD of each article, including articles
that have not yet translated (which have an inverse
TD of zero). If TC= 1, then all articles are cited by
H articles in exactly one generation; if TC=0, then
no articles have translated.
Table 1c lists the TF, TD, TY, and TC of each category.
A, C, and AC articles take more citation generations and
more time to reach H articles than AH, CH, and ACH
articles, which is consistent with the results from the
previous section. C articles require the most generations
(TD =3.08), though A articles require the longest time
(TY= 10.40 years). Even H articles take 5.69 years, on
average, before being cited by another H article.
The colors in Figure 1 indicate the average TD of dif-
ferent disciplines. There is a clear relationship between
the TD and the position along the Translational Axis.
For example, Nursing consists of mostly H articles (TI =
0.98), and nearly every article, when cited, is cited by an
H article (TD =1.09). Allergy and Immunology is near
the ACH point (TI=0.02) and requires an additional
citation generation to reach an H article (TD = 2.29).
Botany is furthest from the H point (TI= −0.46) and re-
quires almost four citation generations (TD =3.88).
Training more physician-scientists could accelerate
translation
Physician-scientists are essential in bridging the gap be-
tween basic research and clinical medicine and reducing
the time to translation [24,27,28]. Zemlo notes that inves-
tigators with combined MD-PhD degrees play a particu-
larly pivotal role in translation--they represent just 2.5% of
medical school graduates each year, but have a third of the
NIH grants going to physician-scientists [27].
Figures 4 and 5 plot all faculty from Harvard Medical
School, separated by degree (PhD; MD-PhD; and MD),
onto the Triangle of Biomedicine based on the articles they
have published. The majority of faculty lie close to the
Translational Axis—the line connecting AC and H, with
fewer near the A and C points. Most faculty near H
(TI =1) have MD degrees, most faculty near AC (TI=−0.5)
have PhD degrees, and faculty with both MD and PhD de-
grees are most likely to be near the ACH point (TI=0).
Figure 3 Information flow between categories as measured by corrected citation counts. Arrow size represents the percentage of citations
of the category at the tail of the arrow. Circle area is proportional to the number of articles in that category.
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fective physician-scientist and translational researcher, fac-
ulty with MD-PhD degrees are most active at the points in
the Triangle of Biomedicine though which translation typic-
ally occurs. Though beyond the scope of this study, one can
also imagine performing similar analysis on groups of in-
vestigators, rather than at the individual person level, to de-
termine if there are types of transdisciplinary teams that are
likely to perform translational research.
Discussion
Although the Triangle of Biomedicine is not meant to
replace the traditional qualitative definitions of T1-T4
translational research [7], it provides a quantitative tech-
nique to measure translation and to determine how long
it takes. This is important to policy makers in evaluating
the impact of the large investments being made to accel-
erate translation. The Triangle of Biomedicine also pro-
vides a simple visual way of depicting this impact, which
can be far more powerful than numbers alone.
As with other bibliometric techniques, it is important
not to overgeneralize metrics. The position of a broad dis-
cipline on the Triangle of Biomedicine simply represents
the average of thousands of publications. Predicting the
potential impact of a specific research area or an individ-
ual article or scientist requires far more information;
Figure 4 Plots of all faculty from Harvard Medical School, separated by degree. The large green diamond is the average position of faculty
with PhD degrees; the large red circle is the average position of faculty with MD, PhD degrees; and the large blue square is the average position
of faculty with MD degrees.
Figure 5 The percentage of faculty with different degree types along the AC-H translational axis.
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multidimensional scoring system has been developed to as-
sess the “translatability” of drug development projects
[29,30]. This may indeed be a superior method, but it re-
quires manual review of the literature and therefore might
not be scalable. Fontelo identified 59 words and phrases,
which when present in the titles or abstracts of articles, sug-
gest that the article is translati o n a l[ 3 1 ] .H o w e v e r ,t h a ti sa n
all-or-nothing approach, which does not take into account
the full spectrum from basic research to clinical medicine.
This work is limited in several ways. It takes at least a
year for most articles to be assigned MeSH descriptors.
During that time the articles cannot be classified using the
method described in this paper. Also, our classification
method is based on a somewhat arbitrary set of MeSH de-
scriptors—different descriptors could have been used to
map articles to A-C-H categories. However, the ones we
used seemed intuitive and they produced results that were
consistent with Narin’s classification schemes. Finally, any
metric based on citation analysis is dependent on the par-
ticular citation database used, and there are significant dif-
ferences among the leading databases [22]. In this study,
we used citations in PubMed that are derived from
PubMed Central because they are freely available in their
entirety, and therefore our method can be used without
subscriptions to commercial citation databases, such as
Scopus and Web of Science, which are cost-prohibitive to
most people. However, because these commercial data-
bases have a greater number of citations and index differ-
ent journals than PubMed, they might show shorter or
alternative paths towards translation (i.e., fewer citation
generations or less time). Though, as described in our
Methods, there is evidence that suggests these differences
might be relatively small. Selecting the best citation data-
base for identifying translational research is a topic for fu-
ture research.
Another area of future research could attempt to iden-
tify a subset of H articles that truly reflect changes in
health practice and create a separate category P for these
articles. This might be possible, for example, by using
Khoury’s approach of using PubMed’s “publication type”
categorization of each article to select for those that are
clinical trials or practice guidelines [7]. This could be vi-
sualized in the Triangle of Biomedicine by moving H ar-
ticles to the center of the triangle and placing P articles
in the lower-right corner, thereby highlighting research
that has translated beyond H into health practice.
Conclusions
The Triangle of Biomedicine is a novel way to identify
translational science and track changes over time. This
is important to policy makers in evaluating the impact of
the large investments being made to accelerate transla-
tion. As with any metric, its limitations and potential
biases should always be kept in mind. As a result, it
should be used to supplement rather than replace alter-
native methods of measuring or defining translational
science. What is unique, though, to the Triangle of Bio-
medicine, is its simple visual way of depicting transla-
tion, which can be far more powerful to policy makers
than numbers alone.
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